Abstract:The injury-triggered reocclusion (restenosis) of arteries treated with angioplasty to relieve atherosclerotic obstruction remains a challenge due to limitations of existing therapies. A combination of magnetic guidance and affinity-mediated arterial binding can pave the way to a new approach for treating restenosis by enabling efficient site-specific localization of therapeutic agents formulated in magnetizable nanoparticles (MNPs) and by maintaining their presence at the site of arterial injury throughout the vulnerability period of the disease. In these studies, we investigated a dual-targeted antirestenotic strategy using drug-loaded biodegradable MNPs, surface-modified with a fibrin-avid peptide to provide affinity for the injured arterial wall. The MNPs were characterized with regard to their magnetic properties, efficiency of surface functionalization, disassembly kinetics, and interaction with fibrin-coated substrates. The antiproliferative effects of MNPs formulated with paclitaxel were studied in vitro using a fetal cell line (A10) exhibiting the defining characteristics of neointimal smooth muscle cells. Animal studies examined the efficiency of combined (physical/affinity) MNP targeting to stented arteries in Sprague Dawley rats using fluorimetric analysis and fluorescent in vivo imaging. The antirestenotic effect of the dual-targeted therapy was determined in a rat model of in-stent restenosis 28 days post-treatment. The results showed that MNPs can be efficiently functionalized to exhibit a strong binding affinity using a simple two-step chemical process, without adversely affecting their size distribution, magnetic properties, or antiproliferative potency. Dual-targeted delivery strongly enhanced the localization and retention of MNPs in stented carotid arteries up to 7 days post-treatment, while minimizing redistribution of the carrier particles to peripheral tissues. Of the two targeting elements, the effect of magnetic guidance was shown to dominate arterial localization (p = 0.004 vs. 0.084 for magnetic targeting and peptide modification, respectively), consistent with the magnetically driven MNP accumulation step defining the extent of the ultimate affinity-mediated arterial binding and subsequent retention of the carrier particles. The enhanced arterial uptake and sustained presence of paclitaxel-loaded MNPs at the site of stent deployment were associated with a strong inhibition of restenosis in the rat carotid stenting model, with both the neointima-to-media ratio (N/M) and % stenosis markedly reduced in the dual-targeted treatment group (1.62 ± 0.2 and 21 ± 3 vs. 2.17 ± 0.40 and 29 ± 6 in the control animals; p < 0.05). We conclude that the dual-targeted delivery of antirestenotic agents formulated in fibrin-avid MNPs can provide a new platform for the safe and effective treatment of in-stent restenosis.

Feasibility of inhibiting coronary artery restenosis after percutaneous transluminal coronary angioplasty by magnetic induction target hyperthermia treatment

Progress in Preventing and Curing Restenosis by Magnetic Induction Hyperthermia

In Vitro Study On The Feasibility Of Magnetic Stent Hyperthermia For The Treatment Of Cardiovascular Restenosis

Effects of Heating on Vascular Smooth Muscle Cells

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

Targeting and deep-penetrating delivery strategy for stented coronary artery by magnetic guidance and ultrasound stimulation

Wirelessly Heating Stents via Radiofrequency Resonance toward Enabling Endovascular Hyperthermia

Heating Niti Stent in Magnetic Fields and the Thermal Effect on Smooth Muscle Cells

Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Coronary artery stent heating under alternating current magnetic field

Nanomagnetic Actuation of Hybrid Stents for Hyperthermia Treatment of Hollow Organ Tumors

Evaluation on the feasibility and safety of magnetic stent hyperthermia for esophageal cancer

Clinical Study on the Invasive Treatment in Patients with Non-St-elevation Acute Coronary Syndromes Guided by the Magnetic Navigation System

Post-dilatation Improves Stent Apposition in Patients with ST-segment Elevation Myocardial Infarction Receiving Primary Percutaneous Intervention: A Multicenter, Randomized Controlled Trial Using Optical Coherence Tomography.

[Clinical study on the coronary artery interventions guided by the magnetic navigation system]

Targeted delivery of therapeutic agents in a healthy and stenosed patient-specific carotid artery using an external magnetic field

The Effect of Nonuniform Magnetic Targeting of Intracoronary-Delivering Mesenchymal Stem Cells on Coronary Embolisation.

Non-invasive Treatment Efficacy Evaluation for High-Intensity Focused Ultrasound Therapy Using Magnetically Induced Magnetoacoustic Measurement

Lasers in the Treatment of Ischemic Heart Disease in China

Feasibility of the Magnetic Induction Hyperthermia Combined with ~(125)I Brachytherapy